Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | GMAB | JAZZ | ||
| Company | Ascendis Pharma ADR | Genmab A/S ADR | Jazz Pharma Plc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 261.39 | 34.04 | 244.00 | ||
| High | 267.91 | 34.50 | 248.07 | ||
| Low | 257.52 | 33.74 | 241.02 | ||
| Last | 263.91 | 33.93 | 241.43 | ||
| Change | +3.66 | +0.64 | -2.28 | ||
| Percent Change | +1.41% | +1.92% | -0.94% | ||
| Volume | 168,804 | 696,192 | 357,797 | ||
| 20-Day Average Volume | 488,599 | 2,907,252 | 1,045,403 | ||
| Previous | 260.25 | 33.29 | 243.71 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 253.48 | 32.66 | 250.53 | ||
| 20-Day Raw Stochastic | 83.13% | 90.87% | 7.73% | ||
| 20-Day Relative Strength | 58.34 | 65.19 | 46.30 | ||
| Weighted Alpha | +31.13 | +28.69 | +74.65 | ||
| Today's Opinion | 80% Buy | 88% Buy | 64% Buy | ||
| Yesterday's Opinion | 80% Buy | 88% Buy | 64% Buy | ||
| Last Month's Opinion | 56% Buy | 32% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +5.57% since 08/26/26 | +0.56% since 08/26/26 | -2.68% since 08/26/26 | ||
| Low | 246.30 on 08/28/26 | 32.54 on 08/31/26 | 241.02 on 09/02/26 | ||
| High | 268.98 on 08/31/26 | 34.49 on 09/02/26 | 252.85 on 08/27/26 | ||
| 1-Month | |||||
| %Chg | +8.32% since 07/31/26 | +17.56% since 07/31/26 | -4.05% since 07/31/26 | ||
| Low | 239.56 on 08/04/26 | 28.09 on 08/03/26 | 240.63 on 08/14/26 | ||
| High | 268.98 on 08/31/26 | 34.49 on 09/02/26 | 266.38 on 08/25/26 | ||
| 3-Month | |||||
| %Chg | +21.98% since 06/02/26 | +42.31% since 06/02/26 | +7.30% since 06/02/26 | ||
| Low | 203.80 on 06/08/26 | 23.62 on 06/03/26 | 220.74 on 06/18/26 | ||
| High | 282.15 on 07/09/26 | 34.49 on 09/02/26 | 266.38 on 08/25/26 | ||
| 6-Month | |||||
| %Chg | +9.13% since 03/02/26 | +14.47% since 03/02/26 | +27.39% since 03/02/26 | ||
| Low | 203.80 on 06/08/26 | 23.62 on 06/03/26 | 176.67 on 03/06/26 | ||
| High | 282.15 on 07/09/26 | 34.49 on 09/02/26 | 266.38 on 08/25/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 16,233,612 | 20,765,572 | 15,820,435 | ||
| Shares Outstanding, K | 62,377 | 623,778 | 64,915 | ||
| Annual Sales, $M | 814,760,000 | 3,720,000,000 | 4,267,590,000 | ||
| Annual Net Income, $M | -258,000,000 | 963,000,000 | -356,150,000 | ||
| Last Qtr Sales, $M | 394,490,000 | 1,155,000,000 | 1,208,300,000 | ||
| Last Qtr Income, $M | 240,640,000 | 303,000,000 | 192,800,000 | ||
| 60-Month Beta | 0.35 | 0.84 | 0.36 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 3.29 on 08/13/26 | 0.54 on 08/06/26 | 5.71 on 08/03/26 | ||
| Latest Earnings Date | 11/11/26 | 11/05/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 146.13 | 23.86 | 10.85 | ||